GOEDDEL DAVID V
SEC CIK 1182464 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics, Inc. | Dir, 10% | 49.31M | $64.56M | — | 8 | 2021-08-03 | 2025-03-05 |
Most active insiders at TNYA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | COLUMN GROUP III-A, LP | 10% | — | $3.54M |
| 2 | TCG Opportunity III GP, LLC | 10% | — | $2.37M |
| 3 | Ali Faraz | CEO, Dir | — | $32.1K |
| 4 | Tingley Whittemore | Chief Medical Off | — | $14.9K |
| 5 | Higa Tomohiro | SVP, Fin | — | $5,216 |
GOEDDEL DAVID V made no open-market trades at TNYA in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-03-07 | 2025-03-05 | TNYA | Tenaya Therapeutics, Inc. | GOEDDEL DAVID V | Dir, 10% | P - Purchase | $0.7 | +35.71M | 49.31M | +263% | +$25.00M |
| I | 2024-02-14 | 2024-02-12 | TNYA | Tenaya Therapeutics, Inc. | GOEDDEL DAVID V | Dir, 10% | P - Purchase | $4.50 | +2.22M | 13.60M | +20% | +$10.00M |
| I | 2023-03-14 | 2023-03-10 | TNYA | Tenaya Therapeutics, Inc. | GOEDDEL DAVID V | Dir, 10% | P - Purchase | $2.60 | +6,779 | 11.38M | +0.1% | +$17.6K |
| I | 2023-02-10 | 2023-02-08 | TNYA | Tenaya Therapeutics, Inc. | GOEDDEL DAVID V | Dir, 10% | P - Purchase | $2.60 | +1.50M | 11.37M | +15% | +$3.90M |
| I | 2023-01-23 | 2023-01-19 | TNYA | Tenaya Therapeutics, Inc. | GOEDDEL DAVID V | Dir, 10% | P - Purchase | $2.50 | +69.7K | 9.87M | +0.7% | +$174.3K |
| MI | 2023-01-19 | 2023-01-17+ | TNYA | Tenaya Therapeutics, Inc. | GOEDDEL DAVID V | Dir, 10% | P - Purchase | $2.51 | +185.2K | 9.80M | +2% | +$465.1K |
| I | 2022-11-23 | 2022-11-21 | TNYA | Tenaya Therapeutics, Inc. | GOEDDEL DAVID V | Dir, 10% | P - Purchase | $2.60 | +9.62M | 9.62M | New | +$25.00M |
| DMI | 2021-08-04 | 2021-08-03 | TNYA | Tenaya Therapeutics, Inc. | GOEDDEL DAVID V | Dir, 10% | C - Cnv Deriv | $0.00 | +9.35M | 4.41M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations